Skip to main content
. 2015 Sep 14;5(9):e009090. doi: 10.1136/bmjopen-2015-009090

Figure 1.

Figure 1

Study schema for the ‘SIAMMS-II’ trial (EDSS, Expanded Disability Status Scale; GEP, global evoked potential; MSFC, Multiple Sclerosis Functional Composite; MSIS, MS Impact Scale; SIAMMS, Study of Intravenous Autologous Marrow in Multiple Sclerosis).